Még nem toboroz
Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
2026-526419-13-00· 3. fázis· AstraZeneca AB· Forrás
Még nem toboroz
A Study to Evaluate the Efficacy and Safety of CP-012B in Participants With Parkinson’s Disease With Early Morning OFF Episodes
2026-526634-46-00· 2. fázis· Contera Pharma A/S· Forrás
Még nem toboroz
ATRIO Study:
Effect of Romosozumab vs. Denosumab on Coronary Atherosclerotic Damage in Postmenopausal Osteoporosis: A Phase IV, Low-Risk Intervention Study.
2025-522592-29-00· 4. fázis· Ospedale Galeazzi S.p.A.· Forrás
Toboroz
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
2025-523670-17-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Idiopathic Arthritis in Children and Adolescents
NCT07554495· 3. fázis· Alfasigma S.p.A.· Forrás
Toboroz
OLE Study With Filgotinib in JIA
NCT07553182· 3. fázis· Alfasigma S.p.A.· Forrás
Toboroz
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
NCT07286058· 3. fázis· Takeda· Forrás
Toboroz
Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcoma
2024-518167-35-01· 2. fázis· Associazione Italiana Ematologia Oncologia Pediatrica· Forrás
Még nem toboroz
Clinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-groups, randomised controlled trial
2022-503119-40-00· 3. fázis· Azienda Ospedaliera Ordine Mauriziano Di Torino· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
NCT06671483· 3. fázis· Takeda· Forrás
Még nem toboroz
Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
NCT06618937· 4. fázis· Istituto Giannina Gaslini· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325· 3. fázis· UCB Biopharma SRL· Forrás
Fut, nem toboroz
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
NCT06470048· 2. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
NCT06568237· 2. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás
Toboroz
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
NCT06100744· 3. fázis· AbbVie· Forrás
Fut, nem toboroz
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
NCT06331312· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
NCT05925803· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
NCT05985915· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717· 2/3. fázis· GlaxoSmithKline· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
NCT05946941· 3. fázis· Bristol-Myers Squibb· Forrás
Fut, nem toboroz
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
NCT05624749· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
NCT05622708· 4. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
NCT05767047· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A randomized, two-armed, single-blind, parallel, active controlled, and non-inferiority clinical trial to Compare Efficacy and Safety of anti TNF-alfa biosimilar molecules to the originators in children with active Juvenile Idiopathic Arthritis
2024-515557-22-00· 4. fázis· Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico· Forrás
Toboroz
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
NCT04804553· 3. fázis· Amgen· Forrás
Meghívásos bevonás
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
NCT04976322· 3. fázis· UCB Biopharma SRL· Forrás
Fut, nem toboroz
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
NCT03728478· 3. fázis· Istituto Giannina Gaslini· Forrás